148 related articles for article (PubMed ID: 33271290)
1. Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome.
Vita S; Di Bari V; Corpolongo A; Goletti D; Espinosa J; Petracca S; Palmieri F; Nicastri E;
Int J Infect Dis; 2021 Feb; 103():607-610. PubMed ID: 33271290
[TBL] [Abstract][Full Text] [Related]
2. [Consensus of the Genetics Branch of the Chilean Society of Pediatrics on the prioritization of people with Down syndrome and rare diseases for vaccination against SARS-CoV-2].
Faundes V; Pardo R; Cammarata-Scalisi F; Alarcon P; Lay-Son G; San Martin E
Andes Pediatr; 2021 Apr; 92(2):309-315. PubMed ID: 34106172
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and children with Down syndrome: is there any real reason to worry? Two case reports with severe course.
Kantar A; Mazza A; Bonanomi E; Odoni M; Seminara M; Verde ID; Lovati C; Bolognini S; D'Antiga L
BMC Pediatr; 2020 Dec; 20(1):561. PubMed ID: 33339516
[TBL] [Abstract][Full Text] [Related]
4. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19.
De Toma I; Dierssen M
Sci Rep; 2021 Jan; 11(1):1930. PubMed ID: 33479353
[TBL] [Abstract][Full Text] [Related]
5. Are patients with Down syndrome vulnerable to life-threatening COVID-19?
De Cauwer H; Spaepen A
Acta Neurol Belg; 2021 Jun; 121(3):685-687. PubMed ID: 32444942
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 in patients with Down syndrome: A systematic review.
Pitchan Velammal PNK; Balasubramanian S; Ayoobkhan FS; Mohan GVK; Aggarwal P; Rabaan AA; Khan SA; Yasmin F; Koritala T; Surani SR
Immun Inflamm Dis; 2024 Mar; 12(3):e1219. PubMed ID: 38501534
[TBL] [Abstract][Full Text] [Related]
7. Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.
Illouz T; Biragyn A; Iulita MF; Flores-Aguilar L; Dierssen M; De Toma I; Antonarakis SE; Yu E; Herault Y; Potier MC; Botté A; Roper R; Sredni B; London J; Mobley W; Strydom A; Okun E
Front Immunol; 2021; 12():621440. PubMed ID: 34248930
[TBL] [Abstract][Full Text] [Related]
8. Enhancing understanding of SARS-CoV-2 infection among individuals with Down syndrome: An integrative review.
Silva MVGD; Pereira LRG; Avó LRDS; Germano CMR; Melo DG
Sao Paulo Med J; 2023; 142(2):e2023015. PubMed ID: 37610949
[TBL] [Abstract][Full Text] [Related]
9. Specific Susceptibility to COVID-19 in Adults with Down Syndrome.
Illouz T; Biragyn A; Frenkel-Morgenstern M; Weissberg O; Gorohovski A; Merzon E; Green I; Iulita F; Flores-Aguilar L; Dierssen M; De Toma I; Lifshitz H; Antonarakis SE; Yu E; Herault Y; Potier MC; Botté A; Roper R; Sredni B; Sarid R; London J; Mobley W; Strydom A; Okun E
Neuromolecular Med; 2021 Dec; 23(4):561-571. PubMed ID: 33660221
[TBL] [Abstract][Full Text] [Related]
10. Trisomy 21 and Coronavirus Disease 2019 in Pediatric Patients.
Newman AM; Jhaveri R; Patel AB; Tan TQ; Toia JM; Arshad M
J Pediatr; 2021 Jan; 228():294-296. PubMed ID: 32861693
[TBL] [Abstract][Full Text] [Related]
11. Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China.
Zhang L; Dong L; Ming L; Wei M; Li J; Hu R; Yang J
BMC Pregnancy Childbirth; 2020 Jul; 20(1):394. PubMed ID: 32641013
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
13. Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy-A case series.
Villani ER; Carfì A; Di Paola A; Palmieri L; Donfrancesco C; Lo Noce C; Taruscio D; Meli P; Salerno P; Kodra Y; Pricci F; Tamburo de Bella M; Floridia M; Onder G;
Am J Med Genet A; 2020 Dec; 182(12):2964-2970. PubMed ID: 32918520
[TBL] [Abstract][Full Text] [Related]
14. Individuals with Down syndrome hospitalized with COVID-19 have more severe disease.
Malle L; Gao C; Hur C; Truong HQ; Bouvier NM; Percha B; Kong XF; Bogunovic D
Genet Med; 2021 Mar; 23(3):576-580. PubMed ID: 33060835
[TBL] [Abstract][Full Text] [Related]
15. Pneumonia and respiratory infections in Down syndrome: A scoping review of the literature.
Santoro SL; Chicoine B; Jasien JM; Kim JL; Stephens M; Bulova P; Capone G
Am J Med Genet A; 2021 Jan; 185(1):286-299. PubMed ID: 33073471
[TBL] [Abstract][Full Text] [Related]
16. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 in patients with Down syndrome.
Emami A; Javanmardi F; Akbari A; Asadi-Pooya AA
Neurol Sci; 2021 May; 42(5):1649-1652. PubMed ID: 33523318
[TBL] [Abstract][Full Text] [Related]
18. Clinical Spectrum of COVID-19 Cases and their Correlation with S.LDH Levels- An Observational Study from Southeast Rajasthan.
Gupta D; Sharma R; Patwardhan B; Mathur RD
J Assoc Physicians India; 2021 Sep; 69(9):11-12. PubMed ID: 34585882
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome.
Alsohime F; Temsah MH; Al-Nemri AM; Somily AM; Al-Subaie S
J Infect Public Health; 2020 Dec; 13(12):1791-1796. PubMed ID: 33127335
[TBL] [Abstract][Full Text] [Related]
20. Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection.
Chaudhari S; Dey Pereira S; Asare-Warehene M; Naha R; Kabekkodu SP; Tsang BK; Satyamoorthy K
J Ovarian Res; 2021 Feb; 14(1):39. PubMed ID: 33632295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
